InvestorsHub Logo
icon url

Jagman

02/01/08 3:40 PM

#15339 RE: rossi #15336

Sure...they just need to hire about 550 more people and sell two welders at $400 million each......
icon url

lowman

02/01/08 3:56 PM

#15345 RE: rossi #15336

I would say it's doable after about 3-4 years of building up the market.
icon url

maddogs

02/02/08 12:35 PM

#15359 RE: rossi #15336

Isrg is being run in something of a unique manner. Few Surgical companies adhere to staying specialized. Most are happy to get started with the usual or mundane products and if they hit upon an excellent product, still continue to market and acquire new "mundanes". Isrg is staying specialized.

Lack of specialization inevitably thins efforts and results. Some co.s attain cap. by taking everything they can, some don't. The best, imo, try to use synergy in product promotion and selection.

The easiest understood models are appreciated, usually, the quickest and most fully. Isrg has about 700 units out ( about 8 years of marketing)@ about 1.25 mill ea.. By memory, lol, revs reflected from 50% units, 25% tools, 25% training. That's a LOT of training, paid for, but still a TON of ongoing effort needed to make the product viable.

It took 2 years , <>, to establish itself as a unique model,
and take off. Those percentages will parallel growth till something changes in growth.

LTC, guesstimating, will sell for .02 mill a genset. Established "Handset" models show revs 90% tools 10% gensets and training almost what one could see as negligible.

This is the fundamental difference. Both platforms have continuing potentials and restrictions. As things unfold I believe having LTC (ex Acmi-Circon-Gyrus) management that has from the ground up, to V.P experience, will enable several important features in this co..

Every inventor that has patented an invention and looked to see the maximum rewards, sees lost opportunities. The plainly, obviously, priorly successful, LTC managers have already applied this concern with the subsidization into 6 initial subs. Also by looking for major co.s and distributors. Also by hitting all premium world markets (that are not known to have serious concerns patent theft wise,lol).

As I see it, the "curve" on appreciation of LTC has more potential than Isrgs due to the ability involve other Surgical industry participants. When looking at cap. expectations for LTC, keep in mind, margins, costs, Roi time frames ect ect. are different from robotics. For example, the growth factor or annual increase. Isrg is not going to have 50% annum growth, imo.

Can LTC attain the revs Isrg has? in 8 Years? I'm not sure.
Does it matter, at least for the next 2 years? I'm pretty sure not as the curve should be ahead of Isgr in time frames. IMO.